Novavax, Inc.
Key Metrics
Market Snapshot
About
Novavax, Inc. is a biotechnology company that develops next-generation vaccines for serious infectious diseases. The company gained prominence with its protein-based COVID-19 vaccine (Nuvaxovid) and is advancing candidates for influenza, COVID-flu combination vaccines, and other respiratory diseases. Novavax uses proprietary recombinant nanoparticle technology and Matrix-M adjuvant to enhance immune response.